Rothia mucilaginosa bacteremia: A 10-year experience of a pediatric tertiary care cancer center.

Pediatr Blood Cancer

Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Published: July 2019

Rothia mucilaginosa is part of the oral and upper respiratory tract flora. Usually, this gram-positive coccus is not pathogenic; however, in the setting of immunosuppressed hosts, it can cause life-threatening infections as an opportunistic pathogen. Among a cohort of 1511 hematologic-oncologic patients at a pediatric tertiary care cancer center, we identified five cancer patients (0.35%) within a period of 10 years having a proven Rothia mucilaginosa bacteremia (1 culture positive: n = 3/5; > 1 culture positive: n = 2/5). With prompt and adequate antibiotic treatment, infection resolved rapidly before recovery of neutrophils and without any sequelae, suggesting that Rothia mucilaginosa bacteremia without organ involvement is not exceptionally problematic in pediatric cancer patients.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27691DOI Listing

Publication Analysis

Top Keywords

rothia mucilaginosa
16
mucilaginosa bacteremia
12
pediatric tertiary
8
tertiary care
8
care cancer
8
cancer center
8
cancer patients
8
culture positive
8
rothia
4
bacteremia 10-year
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!